That rehash of the Ritenga data made me think of the video that was playing in a loop in the NWBio booth at ASCO which illustrated the way single target therapies did a real good job of getting rid of the targets.... just like you said, but not the tumor. Now I wonder if that wasn't Linda's way of making a not too subtle dig at AF and his "optimistic" article about Celldex. I just had a giggle thinking that must have been just the point she was making.
Thanks senti for educating us. I see the difference in these drugs that they attack one protein and in cldx case, it no more works in the rGBM case. Even attacking 6 proteins by IMUC, still not enough. Very interesting. thanks!